Raymond James & Associates’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$605K	Buy	13,455 +2,926	+28%	+$132K	﹤0.01%	2983
2024 Q2	$365K	Sell	10,529 -422	-4%	-$14.6K	﹤0.01%	3232
2024 Q1	$317K	Buy	+10,951	New	+$317K	﹤0.01%	3320